Neurodegenerative Diseases: From Risk Factors to Treatments

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".

Deadline for manuscript submissions: closed (28 April 2026) | Viewed by 1122

Special Issue Editor


E-Mail Website
Guest Editor
Health Department, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, 71013 Foggia, Italy
Interests: dementia; neuropsychiatric symptoms; neuropsychology; psychobiology; natural compounds; information and communication technology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Neurodegenerative diseases share some fundamental characteristics, including the gradual progression of symptoms and the significant impact on the autonomy and quality of patients’ lives. Despite the different causes and manifestations, the common denominator is the deterioration of neural capacities, which leads to motor difficulties, memory problems, mood changes, and other complications.

The exact causes of neurodegenerative diseases are not always clear, but numerous studies suggest an interaction between genetic, environmental, and lifestyle factors.

The central focus of this Special Issue will be to advance novel therapeutic models that have shown exceptional promise in clinical models of NDs. The aim will be to individualize genetic and clinic mechanisms of NDs considering age-related and multidimensional approaches for the purpose of appropriate and personalized treatment, along with the use of information and communication technology (ICT) tools, which can decrease hospitalization and increase permanence at home.

Pharmacologic treatment delivers limited symptomatic benefits, so the provision of non-pharmacological treatments in addition to standard outpatient care is an asset of good clinical practice.

Therefore, prognostic evaluation of patients with NDs plays a key role in the decision analyses of care processes including the organization of the social health care system, the support to families, caregivers, and patients, as well as the choice of appropriate treatment.

Dr. Grazia D’Onofrio
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • immune regulation (e.g., chronic inflammation) of NDs
  • cardiocerebral vascular disease and NDs
  • the effects of emotional and affective dimensions on cognitive reserve decline
  • the multidimensional screening of NDs
  • the interventions of NDs
  • gene polymorphism on the efficacy of pharmacological treatments in NDs
  • cognitive and functional rehabilitation for patients with NDs
  • technology innovation in the integrated approach to the patients with NDs

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

25 pages, 5908 KB  
Article
Mapping the Polar Neuro-Interactome of Garcinia mangostana Against the AD-PD-ALS Nexus
by Rahni Hossain, Sirirat Surinkaew, Pradoldej Sompol, Nasmah K. Bastaki, Rifat Jafrin, Nazim Sekeroglu and Jitbanjong Tangpong
Life 2026, 16(4), 580; https://doi.org/10.3390/life16040580 - 1 Apr 2026
Viewed by 570
Abstract
Background/Objectives: Neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Amyotrophic lateral sclerosis (ALS) share common molecular pathways, including neuroinflammation and oxidative stress, which complicate the effectiveness of single-target treatments. Garcinia mangostana L. (mangosteen) has shown neuroprotective properties, but previous studies focused on lipophilic xanthones, [...] Read more.
Background/Objectives: Neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Amyotrophic lateral sclerosis (ALS) share common molecular pathways, including neuroinflammation and oxidative stress, which complicate the effectiveness of single-target treatments. Garcinia mangostana L. (mangosteen) has shown neuroprotective properties, but previous studies focused on lipophilic xanthones, which have poor bioavailability and uncertain blood–brain barrier permeability. Methods: In the current study, polar metabolites from G. mangostana peel aqueous extract (GMPE) were assessed for potential multi-target interactions via UHPLC-QTOF-MS-based metabolomics, systems pharmacology, and molecular docking analysis. Further, in silico ADMET screening and network-based analyses assessed for overlap between GMPE compounds and genes associated with neurodegeneration (AD, PD, ALS). Results: Analysis of genes linked to AD, PD, and ALS revealed 121 common molecular targets influenced by GMPE metabolites. Network and enrichment analyses indicated that the compounds derived from GMPE may be involved in common pathways related to oxidative stress, neuroinflammation, and neuronal survival. Molecular docking analyses suggest that selected metabolites are likely to exhibit moderate binding affinities to their respective protein targets. Conclusions: The results presented in this study provide evidence that GMPE may possess potential multi-target interactions within common neurodegenerative pathways. However, since the data are based on computational and predictive approaches, these results should be considered hypothesis-generating and warrant further experimental validation. Full article
(This article belongs to the Special Issue Neurodegenerative Diseases: From Risk Factors to Treatments)
Show Figures

Figure 1

Back to TopTop